Achievements

TBDA member organizations and their representatives have reached the following goals or acquired recognition:

Clinical Trials

The following trials have been, or are currently being run on, candidates identified by TBDA member organization(s)

NCT NumberCompoundPhaseStart DateOwner(Originator)Target
NCT05382312GSK-65622022-07-26GSKLeuRS
NCT04176250TBA-737112017-08-29TB AllianceDprE1
NCT04176250TBA-73712 (EBA)2020-01-16Gates MRIDprE1
NCT03758612TBI-2231 (SAD)2019-01-16TB Allianceribosome
NCT04865536TBI-2231 (MAD)2021-02-16TB Allianceribosome
NCT04890535TBAJ-5871 (SAD)2020-12-01TB AllianceATP synthase
NCT04493671TBAJ-8761 (SAD)2020-06-08TB AllianceATP synthase
NCT04472897GSK-2861 (SAD)2020-10-30GSKAdenylyl cyclase
GSK-830terminatedGSKLeu-RS
JNJ-2901terminatedJanssenCyt-BC
NCT05824091MK-776212023-02-23Gates MRI(MSD)Oxazolidinone
NCT05388448Sanfetrinem22022-04-21GSKBeta-lactam

Organizational Recognition

The following TBDA member organizations have been recognized for their work:

Individual Recognition

The following TBDA member organization representatives have been recognized for their work:

Dr. Carl F. Nathan Chairman of Microbiology and Immunology, Weill Cornell Medical College NewYork-Presbyterian Hospital Photography by John Abbott www.johnabbottphoto.com 212-765-2342